Gabriel Braley
Overview
Explore the profile of Gabriel Braley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
1082
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
De Vivo D, Bertini E, Swoboda K, Hwu W, Crawford T, Finkel R, et al.
Neuromuscul Disord
. 2019 Nov;
29(11):842-856.
PMID: 31704158
Spinal muscular atrophy (SMA) is a neurodegenerative disease associated with severe muscle atrophy and weakness in the limbs and trunk. We report interim efficacy and safety outcomes as of March...
2.
Nichols A, Lubaczewski S, Liang Y, Matschke K, Braley G, Ramey T
Int J Clin Pharmacol Ther
. 2014 Aug;
52(10):830-41.
PMID: 25138680
Background: Potential drugdrug interactions are a concern for patients taking tamoxifen. Objective: This study was designed to determine the effect of coadministering desvenlafaxine on tamoxifen pharmacokinetics. Materials And Methods: This...
3.
Ranganathan M, Carbuto M, Braley G, Elander J, Perry E, Pittman B, et al.
Int J Neuropsychopharmacol
. 2012 Jan;
15(9):1251-64.
PMID: 22243563
Although a wealth of preclinical evidence indicates an interplay between the μ-opioid (MOR) and cannabinoid 1 receptor (CB1R) systems, the precise nature of the cross modulation in humans is unclear....
4.
Carbuto M, Sewell R, Williams A, Forselius-Bielen K, Braley G, Elander J, et al.
Psychopharmacology (Berl)
. 2011 Aug;
219(3):885-96.
PMID: 21845389
Rationale: Delta-9-tetrahydrocannabinol (THC) is one of the few cannabinoid receptor ligands that can be used to probe the cannabinoid system in humans. Despite increasing interest in the cannabinoid receptor system,...
5.
Ranganathan M, Braley G, Pittman B, Cooper T, Perry E, Krystal J, et al.
Psychopharmacology (Berl)
. 2008 Dec;
203(4):737-44.
PMID: 19083209
Background: Cannabis is one of the most widely used illicit substances, and there is growing interest in the therapeutic applications of cannabinoids. While known to modulate neuroendocrine function, the precise...
6.
DSouza D, Braley G, Blaise R, Vendetti M, Oliver S, Pittman B, et al.
Psychopharmacology (Berl)
. 2008 Jan;
198(4):587-603.
PMID: 18228005
Introduction: Cannabinoids produce a spectrum of effects in humans including euphoria, cognitive impairments, psychotomimetic effects, and perceptual alterations. The extent to which dopaminergic systems contribute to the effects of Delta-9-tetrahydrocannabinol...
7.
DSouza D, Ranganathan M, Braley G, Gueorguieva R, Zimolo Z, Cooper T, et al.
Neuropsychopharmacology
. 2008 Jan;
33(10):2505-16.
PMID: 18185500
Cannabis is one of the most widely used illicit substances and there is growing interest in the association between cannabis use and psychosis. Delta-9-Tetrahydrocannabinol (Delta-9-THC) the principal active ingredient of...
8.
DSouza D, Gil R, Madonick S, Perry E, Forselius-Bielen K, Braley G, et al.
Neuropsychopharmacology
. 2006 Sep;
31(12):2767-75.
PMID: 16985503
The purpose of this study was to determine whether schizophrenia was associated with alterations in alcohol response that might explain the elevated risk for AUDs in this population. In a...
9.
DSouza D, Abi-Saab W, Madonick S, Forselius-Bielen K, Doersch A, Braley G, et al.
Biol Psychiatry
. 2005 Mar;
57(6):594-608.
PMID: 15780846
Background: Recent advances in the neurobiology of cannabinoids have renewed interest in the association between cannabis and psychotic disorders. Methods: In a 3-day, double-blind, randomized, placebo-controlled study, the behavioral, cognitive,...
10.
DSouza D, Perry E, Macdougall L, Ammerman Y, Cooper T, Wu Y, et al.
Neuropsychopharmacology
. 2004 Jun;
29(8):1558-72.
PMID: 15173844
Recent advances in the understanding of brain cannabinoid receptor function have renewed interest in the association between cannabinoid compounds and psychosis. In a 3-day, double-blind, randomized, and counterbalanced study, the...